Lipid Genomics Products

The mission at Lipid Genomics is to use a personalized medicine approach to develop diagnostics and therapeutics for patients with LAG3 deficiency.

As such, we have developed two product lines:
​

• Diagnostic assay for lymphocyte activation gene-3 as a biomarker for LAG3 deficiency, dysfunctional HDL-cholesterol and other chronic inflammatory diseases. 

• Recombinant human biologic as replacement therapy for patients with LAG3 deficiency.